首页>
外国专利>
USE OF NARINGENIN IN PREPARING DRUGS FOR PREVENTING AND/OR TREATING ABDOMINAL AORTIC ANEURYSM
USE OF NARINGENIN IN PREPARING DRUGS FOR PREVENTING AND/OR TREATING ABDOMINAL AORTIC ANEURYSM
展开▼
机译:萘丁宁在预防和/或治疗腹主动脉瘤的药物中的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention discloses a new use for naringenin as a drug. The new use disclosed in the present invention is the use of naringenin for preparing products for preventing and/or treating abdominal aortic aneurysms. The products comprise drugs and/or health care products. The present invention uses two clinically associated abdominal aortic aneurysm disease models: using angiotensin II (1000 ng/kg/min) through subcutaneous submerging pump to induce ApoE knockout mice; and using calcium phosphate (0.5 M) to daub the abdominal aortas of locally induced C57 mice with abdominal aortic aneurysms. Experiments demonstrate that naringenin via oral gavage can significantly inhibit the onset and development of an abdominal aortic aneurysm in the CaPO 4 daubed and Angll submerging pump induced mice, and thereby naringenin can be used in the treatment of patients with abdominal aortic aneurysms.
展开▼
机译:本发明公开了柚皮苷作为药物的新用途。本发明公开的新用途是柚皮素在制备用于预防和/或治疗腹主动脉瘤的产品中的用途。产品包括药物和/或保健产品。本发明使用两种临床相关的腹主动脉瘤疾病模型:通过皮下浸没泵使用血管紧张素II(1000ng / kg / min)诱导ApoE基因敲除小鼠;和通过血管紧张素II(1000ng / kg / min)诱导皮下浸润。然后使用磷酸钙(0.5 M)涂抹局部诱导的C57腹主动脉瘤的腹主动脉。实验表明,通过口服管饲的柚皮苷可以显着抑制CaPO 4浸润和Angll浸没泵致小鼠的腹主动脉瘤的发作和发展,因此柚皮苷可以用于治疗腹主动脉瘤患者。
展开▼